People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Eli Lilly › Eli Lilly (NYSE: LLY) has been a terrific stock to own over the past 15 years; it has consistently outperformed ...

The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...

Serena Williams, the tennis icon, has revealed her postpartum weight loss journey, shedding 31 pounds with the help of GLP-1 ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...

Serena Williams turned to a weight loss medication and it is paying off massively as the American tennis icon reveals she ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Serena Williams revealed she's been using Zepbound for weight loss after childbirth after fans started commenting on her ...

Serena Williams finally comes clean about her drastic weight change. She shares she lost 31 pounds through weight loss ...

Serena Williams reveals a 31-pound weight loss with Zepbound after fan concern, crediting the drug for transforming her ...